Expert Pitch

Business experts are available to comment on the challenges of COVID-19 vaccine shortages, distribution, and demand.

Indiana University
29-Jan-2021 4:15 PM EST, by Indiana University

INDIANAPOLIS and BLOOMINGTON, Ind. -- Alleviating the coronavirus pandemic rests on worldwide vaccination efforts, but many countries are reporting dwindling supplies of the COVID-19 vaccine. At the same time, the Biden administration aims to buy 200 million more doses, to provide enough vaccine for the entire adult U.S. population by the end of the summer. How will drugmakers like Moderna and Pfizer be able to meet the demand and handle the enormous logistical challenges of distributing doses? Experts from Indiana University Bloomington and IUPUI are available to discuss these topics.

Amrou Awaysheh

Expertise: Corporate social responsibility, operations management, supply chain management, data science and analytics, business innovation, disruptive technology.

Amrou Awaysheh is an assistant professor of operations management at the Kelley School of Business. He is also the director of the Global Supply Chain Enterprise. His research focuses on how firms manage socially responsible practices in their operations and supply chains and the impact that has on firm performance.

Kyle Cattani

Expertise: Operations management, supply chain management, managing operations in the presence of uncertainty, managing product end-of-life, mass customization.

A member of the IU Kelley School of Business faculty since 2005, Kyle Cattani is professor of operations management, chair of the Full-Time MBA Program and the SungKyunKwan Professor. Since 2017, he has served as associate editor of the Journal of Operations Management, and he also is senior editor at Production and Operations Management Society.

Maryam Khatami

Expertise: Stochastic programming, healthcare systems engineering, supply chain management, energy

Maryam Khatami is an expert on stochastic programming applied to healthcare systems engineering, supply chain management, and energy. She has the experience of collaborating with several hospitals to improve patient flow and reduce congestion in hospitals, more specifically in the emergency department. She has also conducted research on supply chain network design and location-routing problems. She develops rigorous mathematical models to formulate and solve these problems using real data​. She received her Ph.D. in Industrial and Systems Engineering from Texas A&M University and B.S. and M.S. degrees in industrial engineering from Amirkabir University of Technology, Iran.

Mohan Tatikonda

Expertise: International trade, Lean Six Sigma, complex new product and service development, startup firms, supply chain management, global competition, corporate strategy, international manufacturing competitiveness, entrepreneurship, incubators, health care delivery, life sciences.

Mohan Tatikonda is a professor of operations management at the Indiana University Kelley School of Business whose research focuses on how firms can most effectively design, develop, introduce and improve products, services and organizational processes. His research addresses managing development projects in global environments, fostering technology transfer in the supply chain, behavioral decision-making by supply chain managers, six-sigma program and project effectiveness, and the consumer privacy implications of RFID technology and other advanced technologies.



Filters close

Showing results

110 of 5833
Newswise: Biophysical Study Sheds Light on Potentially Druggable Process of SARS-CoV-2 Replication
Released: 16-Jun-2021 12:50 PM EDT
Biophysical Study Sheds Light on Potentially Druggable Process of SARS-CoV-2 Replication
National Institute of Biomedical Imaging and Bioengineering

This study investigates how the nucleocapsid protein, or N protein, of the SARS-CoV-2 virus packages the viral genome.

Newswise: ‘Wonder material’ can be used to detect COVID-19 quickly, accurately
Released: 16-Jun-2021 11:55 AM EDT
‘Wonder material’ can be used to detect COVID-19 quickly, accurately
University of Illinois at Chicago

Researchers at the University of Illinois Chicago have successfully used graphene — one of the strongest, thinnest known materials — to detect the SARS-CoV-2 virus in laboratory experiments.

Newswise: UCLA-led Research Finds Connections Between Air Quality and COVID Vulnerability
Released: 16-Jun-2021 11:05 AM EDT
UCLA-led Research Finds Connections Between Air Quality and COVID Vulnerability
UCLA Fielding School of Public Health

Even as governments across the United States consider lifting mask mandates and relaxing preventative measures as vaccination numbers creep up, new research from a UCLA-led team has found that such basic techniques significantly reduce the risk of getting COVID-19. In addition, the research found that U.S. counties with higher exposures to poor air quality, historically, saw higher county-level COVID-19 mortality rates in 2020.

Newswise: Story Tips from Johns Hopkins Experts on COVID-19
Released: 16-Jun-2021 11:00 AM EDT
Story Tips from Johns Hopkins Experts on COVID-19
Johns Hopkins Medicine

NEWS STORIES IN THIS ISSUE: - Stressed About “Returning to Normal”? Here Are Tips to Ease Into the Transition - Be Your Brother’s Keeper: Steps for Faith-Based Communities to Reopen Safely

Newswise: Virtual Event For June 17, 11AM EDT: COVID-19 Vaccines and Male Fertility
Released: 16-Jun-2021 8:55 AM EDT
Virtual Event For June 17, 11AM EDT: COVID-19 Vaccines and Male Fertility
Newswise

This upcoming JAMA-published study examined whether the COVID-19 vaccine impacts male fertility.

Released: 16-Jun-2021 8:00 AM EDT
Two COVID-19 Vaccines Show Safety, Strong Immunity in Infant Model
University of North Carolina School of Medicine

The Moderna mRNA vaccine and a protein-based vaccine candidate elicited durable neutralizing antibody responses to SARS-CoV-2 in pre-clinical research. There were no adverse effects.

access_time Embargo lifts in 2 days
Embargo will expire: 17-Jun-2021 5:00 AM EDT Released to reporters: 16-Jun-2021 5:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 17-Jun-2021 5:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Data and Safety Review Board Reports How it Monitored the COVID-19 Vaccine Trials
Released: 15-Jun-2021 2:55 PM EDT
Data and Safety Review Board Reports How it Monitored the COVID-19 Vaccine Trials
University of Alabama at Birmingham

Evaluation of three vaccine candidates during the COVID-19 pandemic fell to 12 experts of the federally appointed COVID-19 Vaccine Data and Safety Monitoring Board. This team has now taken the unusual step of publishing details of their review process in The Journal of Infectious Diseases.

Released: 15-Jun-2021 1:55 PM EDT
NCCN Policy Summit Explores How COVID-19 Pandemic Can Lead to Improvements in Cancer Care
National Comprehensive Cancer Network® (NCCN®)

NCCN Policy Summit examines the impact of the past year on oncology policy in the U.S., such as resuming recommended screening and clinical trials, applying health innovations from the COVID-19 pandemic to cancer treatment, and addressing systemic inequalities that lead to disparities in outcomes.


Showing results

110 of 5833

close
2.14335